New advances in the treatment of type 2 diabetes

A tétel rövid nézete
dc.contributor.advisorPórszász, Róbert
dc.contributor.advisordeptDepartment of Pharmacologyhu_HU
dc.contributor.authorAlshehri, Abdulaziz Omair M
dc.contributor.departmentDE--Általános Orvostudományi Karhu_HU
dc.contributor.opponentSzentmiklósi, József András
dc.contributor.opponentDrimba, László
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.contributor.opponentdeptKenézy Kórház, Központi Aneszteziológiai és Intezív Terápiás Osztályhu_HU
dc.date.accessioned2020-10-15T09:46:39Z
dc.date.available2020-10-15T09:46:39Z
dc.date.created2017-08-20
dc.description.abstractDiabetes mellitus is characterized by chronic hyperglycemia with disturbances of carbohydrate , fat and protein metabolism resulting from defects in insulin secretion , insulin action , or both . The prevalence of diabetes is rapidly rising all over the globe at an alarming rate . Recent advances in the treatment of type 2 diabetes seek to address these shortfalls . Modern oral hypoglycemic agents may be used with or in place of traditional therapies . Analogue insulins , whose pharmacokinetic and pharmacodynamic properties allow patients improved lifestyle flexibility compared with regular insulin , have done much to improve glycemic control . Using these new classes of therapy , physicians should strive to help patients understand and reach the targets for control that we know to be beneficial for the majority of individuals .hu_HU
dc.description.courseáltalános orvoshu_HU
dc.description.courselangangolhu_HU
dc.description.degreeegységes, osztatlanhu_HU
dc.format.extent37hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/296781
dc.language.isoenhu_HU
dc.subjecttype 2 diabeteshu_HU
dc.subject.dspaceDEENK Témalista::Orvostudomány::Farmakológiahu_HU
dc.titleNew advances in the treatment of type 2 diabeteshu_HU
Fájlok
Gyűjtemények
Theses (Faculty of Medicine)